About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...

However, the drugs have their limits -- such as weight-loss plateaus and weight regain after stopping treatment -- and as ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

Wegovy has been shown to help patients lose ... Rival drugs from Eli Lilly in the GLP-1 class, Zepbound for weight loss and Mounjaro for diabetes, were also in short supply this year, but were ...